Abstract:Objective To explore the prevalence andrelevant factors of metabolic syndrome (MS) in obese patients with polycystic ovary syndrome (PCOS),and the relationship with the body composition measured by bioelectrical impedance analysis (BIA).Methods A retrospective analysis was conducted with the questionnaire responses,blood biochemical examination,and body composition analysis results in 90 obese PCOS patients who accepted weight management in Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,from April 2013 to July 2015.We calculated homeostatic model assessment insulin resistance index (HOMA-IR),visceral fat index (VAI) and lipid accumulation index (LAP);identified patients with MS using the International Diabetes Federation consensus definition issued in 2005.Measurement data were compared using t-test;categorical data were compared using chi-square test;relevant factors of MS wereidentified using Logistic regression analysis.Results The mean body mass index (BMI) of the obese PCOS patients was (32.89±3.39) kg/m2;the MS prevalence was 64.44％ (58/90).The MS group had higher systolic blood pressure (SBP),diastolic blood pressure (DBP),triglyceride (TG),fasting insulin level,HOMA-IR,LAP and VAI compared to the non-MS group (all P ＜ 0.05);lower high density lipoprotein cholesterol (HDL-C) than in the non-MS group (P ＜ 0.05);higher lean body mass index (LBMI) than in the nonMS group [(18.83 ± 1.73) kg/m2 vs.(17.96 ± 1.33) kg/m2,t =2.46,P =0.02].The other body composition indexes showed no statistically significant differences between the two groups.Multivariate Logistic regression analysis found that MS was positively correlated with SBP (OR =1.20,95％ CI =1.08-1.33) and VAI (OR =3.12,95％ CI =3.12-7.25),but not with any body composition index.Conclusions Over half of obese PCOS patients have MS,and those with MS present with more severe dyslipidemia,insulin resistance (IR) and higher levels of VAI,LAP and LBMI.The presence of MS in obese PCOS patients may be positively correlated with SBP and VAI,but not with the body composition measured by BIA.Obese PCOS patients need to strictly control their weight.BIA method may not be applicable for PCOS patients with BMI≥34 kg/m2.

The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index

Visceral adiposity index and lipid accumulation product as diagnostic markers of metabolic syndrome in South Indians with polycystic ovary syndrome

Visceral adipose tissue, epicardial fat, and hepatic steatosis in polycystic ovary syndrome: a study of ectopic fat stores and metabolic dysfunction

Dual-energy X-ray absorptiometry and adiposity index are sensitive methods to evaluate central fat accumulation in women with polycystic ovary syndrome and normal body mass index

Fat Distribution and its Correlation with Insulin Resistance, Androgen Markers, and Proinflammatory Cytokines in Polycystic Ovary Syndrome

To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS

Metabolic Deregulations in Patients with Polycystic Ovary Syndrome

Lipid accumulation product better predicts metabolic status in lean polycystic ovary syndrome than that by visceral adiposity index

Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study

Assessment of early vascular changes in adult females with polycystic ovary syndrome: correlation with insulin resistance

Association Between Vitamin D and Metabolic Indexes in Patients with Polycystic Ovary Syndrome

INFLUENCE OF LIFESTYLE ON THE PROGNOSIS OF POLYCYSTIC OVARY SYNDROME

Application of Body Composition Analysis in Patients with Obese Polycystic Ovary Syndrome and Metabolic Syndrome

Polycystic ovary syndrome and adipose tissue

Visceral adiposity index is independently and positively related with impaired glucose regulation in women with polycystic ovary syndrome

Visceral Adiposity Index was Independently Associated with Hyperuricemia in Patients with Polycystic Ovary Syndrome

Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome

Association of Abdominal Obesity, Insulin Resistance, and Oxidative Stress in Adipose Tissue in Women with Polycystic Ovary Syndrome.

The Importance of Diagnosing the Polycystic Ovary Syndrome

Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance

Assessing body composition through anthropometry: Implications for diagnosing and managing polycystic ovary syndrome (PCOS)